Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT01552135 |
Other study ID # |
2011/2567B |
Secondary ID |
|
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
January 2012 |
Est. completion date |
June 2014 |
Study information
Verified date |
March 2020 |
Source |
Oslo University Hospital |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
The investigators want to study if nanoparticles of titaniumdioxide are penetrating skin when
the skin is intact and when the skin is sunburned. The hypothesis is "Does nanotitandioxide
penetrate intact or sunburned skin?"
Description:
In this pilotstudy there are two human volunteers. The study comprises two phases. The first
phase: The volunteers are applying a commercially available sunscreen lotion containing
titanium dioxide nano particles 6 times a day for one week in an area of the back that is
30x20 cm. Before the first application a 2mm punch biopsy is to be taken and examined by
scanning electron microscopy. After applying sunscreen lotion for a week, a new biopsy will
be taken in order to see how far down in the skin the particles have penetrated. In the
second phase: An artificial sunburn will be induced in the same area of the back. They will
thereafter apply the sunscreen lotion 6 times a day like in the first phase. After two days
(estimated time of maximum skin irritation) a biopsy will be taken in order to see if the
nanoparticles have penetrated down in the layers of the skin, and the investigators will also
take a biopsy after a full week of applying the sunscreen lotion. The investigators will also
examine the urine, before and after the use of sunscreen, to see if the investigators can
find the particles there.